|
Poteshkina N.G., Krylova N.S., Mikheeva L.V., Khadzegova A.B.
Anticoagulant therapy in case of atrial fibrillation for patients with chronic kidney disease
|
№3 / 2020
|
|
Murkamilov I.T., Aitbaev K.A., Fomin V.V., Murkamilova Zh.A., Rayimzhanov Z.R., Redjapova N.A., Yusupov F.A.
Braking progression of nephro- and cerebrovascular complications during atrial fibrillation: opportunities of rivaroxaban
|
№1 / 2020
|
|
Bobkova I.N., Gussaova S.S., Stavrovskaya E.V.
Kidney damage in case of obesity: variants of clinical course, mechanisms of development
|
№6 / 2019
|
|
Bakulin I.G., Abatsieva M. P., Skalinskaya M.I., Zhuravleva M.S.
Clinical and medico-social significance of NAFLD through the prism of comorbidity
|
№6 / 2019
|
|
Mazurov V.I., Petrova M.S., Gaydukova I.Z., Inamova O.V., Fonturenko A.Yu., Gaydukova E.K., Shapovalov A.A., Nagirnyak I.M.
Features of gouty arthritis according to the St. Petersburg City register of gout (2016–2018 years)
|
№6 / 2019
|
|
Murkamilov I.T., Aitbaev K.A., Fomin V.V., Murkamilova Zh.A.
Cystatin C as a marker of chronic kidney desease
|
№4 / 2019
|
|
Prometnaya G.A., Batyushin M.M., Bondarenko N.B.
Association of hyperuricemia with metabolism in patients with chronic kidney disease of 5th stage on hemodialysis
|
№3 / 2019
|
|
Polyakova I.V., Borovkova N.Yu., Maslova T.I., Maksimova I.Yu., Zubova S.Yu., Solov’yanova E.N.
View of the vascular stiffness and cardiovascular risk in patients with chronic glomerulonephritis
|
№2 / 2019
|
|
Kazakova I.A., Ievlev Y.N.
Electrophoretic mobility of erythrocytes in patients with chronic renal disease of 5th dialysis stage with different level of arterial pressure
|
№2 / 2019
|
|
Vyalkina N.A., Klyashev S.M., Vyalkina Y.A., Mezhonov E.M., Klyasheva Y.M.
Peculiarities of the daily profile of arterial pressure and its impact on the outcomes of patients with chronic kidneys disease, receiving program hemodialysis
|
№2 / 2019
|
|
NADEEVA R.A., SIGITOVA O.N., KIM T.Yu., KAMASHEVA G.R., KISELYOVA T.A.
Clinical recommendations for correction of carbohydrate metabolism and sugar reducing therapy in patients with type 2 diabetes and chronic renal disease
|
№2 / 2019
|
|
Muchtarov T.A., Skvortsov V.V.
Modern marker of renal dysfunction
|
№8 / 2017
|
Русский
